Title:
COMPOUND HAVING ENHANCING ACTIVITY FOR GLUCAGON-LIKE PEPTIDE-1 RECEPTOR ACTIONS
Document Type and Number:
WIPO Patent Application WO/2017/170826
Kind Code:
A1
Abstract:
The purpose of the invention is to provide a compound useful in the prevention or treatment of diabetes, obesity, and conditions related thereto. The present invention relates to an enhancing agent for glucagon-like peptide-1 receptor actions, the enhancing agent containing a compound represented by formula (I): [in the formula, each symbol is as defined in the specification.] or a salt thereof.
Inventors:
FUJII TOMOHIRO (JP)
OHSUMI KOJI (JP)
KITAJIMA SEIJI (JP)
KITAHARA YOSHIRO (JP)
OHSUMI KOJI (JP)
KITAJIMA SEIJI (JP)
KITAHARA YOSHIRO (JP)
Application Number:
PCT/JP2017/013158
Publication Date:
October 05, 2017
Filing Date:
March 30, 2017
Export Citation:
Assignee:
AJINOMOTO KK (JP)
International Classes:
C07C311/21; A61K31/18; A61K31/275; A61K31/341; A61K31/381; A61K31/4045; A61K31/4196; A61K31/4245; A61K45/00; A61P3/04; A61P3/10; A61P43/00; C07C321/14; C07C335/20; C07D209/20; C07D213/50; C07D213/74; C07D249/12; C07D271/06; C07D295/135; C07D307/52; C07D333/20
Domestic Patent References:
| WO2011109441A1 | 2011-09-09 | |||
| WO2013170112A1 | 2013-11-14 | |||
| WO2014004884A1 | 2014-01-03 | |||
| WO1997038984A1 | 1997-10-23 | |||
| WO2010146236A1 | 2010-12-23 | |||
| WO2000017159A1 | 2000-03-30 | |||
| WO2008109991A1 | 2008-09-18 |
Other References:
See also references of EP 3438091A4
Attorney, Agent or Firm:
TAKASHIMA, Hajime (JP)
Download PDF: